Giants Set to Sign Tyler Mahle, Boost 2026 Rotation

The San Francisco Giants are making a calculated move to steady their starting rotation. They’re reportedly close to a one-year agreement with right-hander Tyler Mahle.

With questions about depth, durability, and payroll flexibility, this signing fits a familiar pattern for the Giants. The team keeps trying to balance short-term competitiveness with a careful long-term approach.

Giants Near One-Year Pact With Tyler Mahle

Reports say San Francisco is finalizing a one-year, $10 million deal with Mahle. Performance incentives could push the total value close to $13 million.

Mahle, now 31, is a classic short-term gamble. He’s shown he can be effective when healthy, but his durability is a real concern.

The Giants went into the offseason needing starting pitching. With Justin Verlander gone in free agency, only Logan Webb and Robbie Ray looked like sure things for the 2026 rotation.

Adding Mahle helps cover that gap. He gives the club a boost without locking them into a long-term deal.

Strong Surface Results Mask Warning Signs

Mahle’s numbers from his injury-shortened 2025 with Texas jump off the page. He posted a sharp 2.18 ERA and, for stretches, looked like a top-of-the-rotation guy.

When he pitched, he often kept Texas in games. But, if you dig a little deeper, some warning signs pop up.

Mahle’s xERA, xFIP, and SIERA were all above 4.00, with a 4.62 SIERA in particular. Those stats hint that he benefited from a fair bit of luck.

Declining Stuff and Ongoing Health Concerns

The Giants could get Mahle on a one-year deal partly because of his recent health issues. Over the last three seasons, he’s managed just 125 total innings after a run of shoulder, forearm, and elbow problems.

His velocity isn’t helping. Mahle’s fastball averaged around 92 mph in 2025, down from his Cincinnati days.

His strikeout rate dropped to 19.1%, which is well below what you’d want from a top starter.

Rotation Depth Still a Fluid Situation

Mahle joins veteran Adrian Houser, who signed a two-year, $22 million deal earlier this offseason. The two are expected to fill out the middle and back end of the rotation.

But there’s still uncertainty behind them. Landen Roupp could be in the mix when healthy, though he hasn’t proven much yet in the majors.

With both Ray and Mahle carrying injury risks, the Giants will probably need help from within.

Payroll Implications and Front Office Strategy

The Giants’ projected 2026 payroll sits around $175 million, not counting Mahle’s deal or a $17 million deferred payment to Blake Snell. When you add those in, the club looks set to go past last season’s $177 million payroll.

The front office seems determined to stay cautious. Instead of big long-term pitching contracts, San Francisco is leaning on short-term, low-risk veterans to keep future options open.

A Sensible Gamble for a Team in Transition

For the Giants, Tyler Mahle brings upside without much obligation. If he stays healthy, he can eat up innings and help steady the rotation.

If injuries crop up again, the financial and roster hit stays pretty minimal. In an era where pitching depth can really swing a season, this move feels like it fits the Giants’ bigger plan.

They want to compete right now, but also protect tomorrow. Nobody wants to get stuck in deals that close off future options, and honestly, who could blame them?

 
Here is the source article for this story: Giants To Sign Tyler Mahle